Skip to main content

Table 2 Analysis of the correlation between CTCs counts with NSCLC clinical stage

From: Establishment and characterization of a patient-derived circulating lung tumor cell line in vitro and in vivo

Stage

No. of cases (n)

CTC count (mean ± SD)

95% CI

rs

P-value

I

26

49.46 ± 13.34

26.04–80.81

− 0.25

0.015

II

17

23.53 ± 13.32

5.28–52.53

III

16

29.88 ± 13.66

6.29–58.37

IV

30

14.63 ± 4.38

8.42–23.50

  1. CTC circulating tumor cells
Back to article page

Cancer Cell International

ISSN: 1475-2867

Contact us